B.C. Centre for Excellence in HIV/AIDS

Population health

The population health research program focuses on further defining the impact of antiretroviral therapy on the health and well-being of people with HIV. Current priorities include:

establish and evaluate the determinants of optimal antiretroviral therapy for HIV infected individuals, as well as evaluating physician awareness and application of treatment guidelines.
establish and probe database linkages with the B.C.-linked Health Database to determine patterns of hospital utilization and physician usage in the HAART era.
eTo foster international collaborative efforts and knowledge transfer with the international ART Cohort Collaboration Study
To identify determinants of high-risk sexual behaviour and substance abuse among young gay and bisexual men.

Research productivity is based on cohort-based research techniques. The population health research team includes individuals with expertise in demography, epidemiology, biostatistics, outcomes research, cohort studies, relational databases, data entry and quality control, and monitoring and evaluation.

ART Collaborative Study
Drug Treatment Program researchers are also involved in a number of international studies. The most notable being the ART collaborative study conducted from the United Kingdom and Switzerland. Prospective cohort studies, like HOMER, were eligible if they had enrolled at least 100 patients with HIV infection and initiated antiretroviral treatment with at least three drugs. A total of 13 cohort studies have so far agreed to participate. Of these 10 are from European countries, two from Canada and one from the USA. Currently, nearly 13,000 HIV-positive patients are enrolled and two studies from this collaborative study have been published in the Lancet.


Home Home Visitor Information Contact us About us Introduction Our mandate Milestones Directors Clinical John Ruedy Immunodeficiency Clinic B.C. HIV/AIDS Drug Treatment Program Therapeutic guidelines Antiretroviral Outreach Program Laboratory Introduction Services Guidelines Research Clinical Population health Studies/projects Laboratory Published Papers CfE Conference Abstracts 2005 2004 2003 2002 2001 2000 1999 Resources and Conferences Education Introduction Video presentations Partnerships Vancouver Coastal Health Authority Prime Trials The Canadian HIV Trials Network University of British Columbia Oak Tree Clinic International News Media releases Forecast Webmail Live Broadcast
	PRINT Research Population health The population health research program focuses on further defining the impact of antiretroviral therapy on the health and well-being of people with HIV. Current priorities include: establish and evaluate the determinants of optimal antiretroviral therapy for HIV infected individuals, as well as evaluating physician awareness and application of treatment guidelines. establish and probe database linkages with the B.C.-linked Health Database to determine patterns of hospital utilization and physician usage in the HAART era. eTo foster international collaborative efforts and knowledge transfer with the international ART Cohort Collaboration Study To identify determinants of high-risk sexual behaviour and substance abuse among young gay and bisexual men. Research productivity is based on cohort-based research techniques. The population health research team includes individuals with expertise in demography, epidemiology, biostatistics, outcomes research, cohort studies, relational databases, data entry and quality control, and monitoring and evaluation. ART Collaborative Study Drug Treatment Program researchers are also involved in a number of international studies. The most notable being the ART collaborative study conducted from the United Kingdom and Switzerland. Prospective cohort studies, like HOMER, were eligible if they had enrolled at least 100 patients with HIV infection and initiated antiretroviral treatment with at least three drugs. A total of 13 cohort studies have so far agreed to participate. Of these 10 are from European countries, two from Canada and one from the USA. Currently, nearly 13,000 HIV-positive patients are enrolled and two studies from this collaborative study have been published in the Lancet.